Vertex Pharmaceuticals · 9 hours ago
Senior Controls Engineer (Contract)
Boston, MA
Full-time, Contract
Hybrid
Senior Level, Lead/Staff
$75/hr - $90/hr
10+ years expVertex Pharmaceuticals is at the forefront of revolutionizing Cell & Gene Therapy, and they are seeking a Senior Controls Engineer to join their innovative team. In this role, you will be responsible for designing and implementing control and automation systems to enhance manufacturing processes and ensure the reliability of life-saving therapies.
BiotechnologyHealth CareMedicalPharmaceutical
Responsibilities
Design control and automation systems from benchtop to commercial across multiple therapeutic modalities. Perform tuning and troubleshooting of control loops, hardware, and software. This will include integrating multiple components and technologies, such as PLCS, relays, valves, MFCs, HMIs, actuators, robotics, and sensors
Programming software, including, but not limited to Ladder Logic, Functional Block Diagram, Structured Text, Sequential Function Charts, and Instruction List. Programming environments include, but are not limited to Rs Logix, TIA Portal, Delta V Programming Environment, B&R Automation Studio, and various robotic programming environments
Design equipment to interface with enterprise level systems, including, but not limited to, Oracle OPM, POMS MES, Ignition SCADA, OSI PI Historian, and Sepasoft Batch management
Design and manage external design of electrical schematics, industrial control panels, and P&IDs
Co-create Machine Safety Risk Assessments. Design equipment and engineering safeguards that meet applicable laws, regulations, and standards
Support FAT, SAT, commissioning, and qualification activities
Provide periodic status updates to Project Management and cross-functional partners
Create phase plans for automation systems and contribute to an automation masterplan
Create and oversee the creation of technical documentation, including, but not limited to URS, FRS, FMEAs, P&IDs, manuals, work instructions, and maintenance plans
Execute assigned duties on time and within budget; proactively communicate delays and other issues to relevant stakeholders
Comply with all regulatory, corporate, and Quality System policies. Support Deviation Management, CAPA, and Change Control activities, as required
Performs other duties as assigned
Qualification
Required
BS or MS in engineering or another relevant discipline
10+ years of experience working within an electrical and controls environment (pharmaceutical, cGxP preferred). Experience with cell & gene therapy is highly desirable
Experience working with Delta V, Allen Bradley, and Siemens
Knowledge and practical experience of Equipment related laws, regulations, and standards
Understanding of cGxP principles and practices and familiarization with ISO 13485, ISO 14971, and 21CFR820 is a plus. Knowledge of global cGMP requirements governing device or combination products
Experience troubleshooting industrial automation, including, but not limited to PLCs, camera systems, and sensors
Must be able to work independently with adequate supervision, multi-task, and support several projects simultaneously
Sense of urgency, ability to act/escalate promptly, and transparently communicate issues to involved stakeholders and management
Must demonstrate strong interpersonal, presentation, and teamwork skills
Company
Vertex Pharmaceuticals
Vertex Pharmaceuticals is focused on the discovery and development of small molecule drugs for the treatment of serious diseases.
5001-10000 employees
H1B Sponsorship
Vertex Pharmaceuticals has a track record of offering H1B sponsorships. Please note that this does not
guarantee sponsorship for this specific role. Below presents additional info for your
reference. (Data Powered by US Department of Labor)
Distribution of Different Job Fields Receiving Sponsorship
Represents job field similar to this job
Trends of Total Sponsorships
2025 (188)
2024 (150)
2023 (111)
2022 (164)
2021 (112)
2020 (80)
Funding
Current Stage
Public CompanyTotal Funding
$657.31MKey Investors
Janssen Belgium
2024-07-10Post Ipo Secondary· $1.11M
2022-05-17Post Ipo Equity· $50M
2009-12-03Post Ipo Equity· $443M
Leadership Team
Reshma Kewalramani
CEO and President
Nina Devlin
Senior Vice President, Chief Communications Officer
Recent News
2026-01-23
Benzinga.com
2026-01-23
2026-01-22
Company data provided by crunchbase